Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Narges Jokar

Showing results (1-10 of 23) with videos related to

Pageof 3
Sort By:
Current Pharmaceutical Design|February 19, 2020
Bench-to-Bedside Theranostics in Nuclear MedicineNarges Jokar, Majid Assadi, Anna Yordanova, et al.
Asia Oceania Journal of Nuclear Medicine & Biology|January 4, 2021
A Path to New Normal of Nuclear Medicine Facilities: Considerations for ReopeningFarhad Abbasi, Ali Gholamrezanezhad, Narges Jokar, et al.
Nuclear Medicine and Molecular Imaging|December 24, 2019
Radioimmunotherapy (RIT) in Brain TumorsAli Gholamrezanezhad, Hossein Shooli, Narges Jokar, et al.
Frontiers in Nuclear Medicine|October 2, 2024
PET tracers in glioblastoma: Toward neurotheranostics as an individualized medicine approachHabibullah Dadgar, Narges Jokar, Reza Nemati, et al.
Current Pharmaceutical Design|February 19, 2020
Precision Medicine Approach in Prostate CancerMajid Assadi, Narges Jokar, Mojtaba Ghasemi, et al.
Nuclear Medicine Review. Central & Eastern Europe|August 12, 2021
State-of-the-art modalities in cardio-oncology: insight from a nuclear medicine approachNarges Jokar, Abdullatif Amini, Mohammadreza Ravanbod, et al.
Clinical Nuclear Medicine|February 25, 2026
Fibroblast Activation Protein Inhibitor Theranostics in Sarcoma: Current Evidence and Future DirectionsEsmail Jafari, Malik E Juweid, Narges Jokar, et al.
World Journal of Nuclear Medicine|January 15, 2020
Advanced modalities of molecular imaging in precision medicine for musculoskeletal malignanciesNarges Jokar, Erik Velez, Hossein Shooli, et al.
Academic Radiology|August 2, 2025
Beyond Cancer: The Role of Radiolabeled Fibroblast Activation Protein Inhibitors (FAPI) in Non-Oncological Molecular ImagingEsmail Jafari, Malik E Juweid, Mehrzad Bahtouee, et al.
World Journal of Nuclear Medicine|May 3, 2022
Comparison of <sup>18</sup> F-NaF Imaging, <sup>99m</sup> Tc-MDP Scintigraphy, and <sup>18</sup> F-FDG for Detecting Bone MetastasesHabibollah Dadgar, Nasim Norouzbeigi, Narges Jokar, et al.
Pageof 3

Showing results (1-10 of 23) with videos related to

Sort By:
Pageof 3
Current Pharmaceutical Design|February 19, 2020
Bench-to-Bedside Theranostics in Nuclear MedicineNarges Jokar, Majid Assadi, Anna Yordanova, et al.
Asia Oceania Journal of Nuclear Medicine & Biology|January 4, 2021
A Path to New Normal of Nuclear Medicine Facilities: Considerations for ReopeningFarhad Abbasi, Ali Gholamrezanezhad, Narges Jokar, et al.
Nuclear Medicine and Molecular Imaging|December 24, 2019
Radioimmunotherapy (RIT) in Brain TumorsAli Gholamrezanezhad, Hossein Shooli, Narges Jokar, et al.
Frontiers in Nuclear Medicine|October 2, 2024
PET tracers in glioblastoma: Toward neurotheranostics as an individualized medicine approachHabibullah Dadgar, Narges Jokar, Reza Nemati, et al.
Current Pharmaceutical Design|February 19, 2020
Precision Medicine Approach in Prostate CancerMajid Assadi, Narges Jokar, Mojtaba Ghasemi, et al.
Nuclear Medicine Review. Central & Eastern Europe|August 12, 2021
State-of-the-art modalities in cardio-oncology: insight from a nuclear medicine approachNarges Jokar, Abdullatif Amini, Mohammadreza Ravanbod, et al.
Clinical Nuclear Medicine|February 25, 2026
Fibroblast Activation Protein Inhibitor Theranostics in Sarcoma: Current Evidence and Future DirectionsEsmail Jafari, Malik E Juweid, Narges Jokar, et al.
World Journal of Nuclear Medicine|January 15, 2020
Advanced modalities of molecular imaging in precision medicine for musculoskeletal malignanciesNarges Jokar, Erik Velez, Hossein Shooli, et al.
Academic Radiology|August 2, 2025
Beyond Cancer: The Role of Radiolabeled Fibroblast Activation Protein Inhibitors (FAPI) in Non-Oncological Molecular ImagingEsmail Jafari, Malik E Juweid, Mehrzad Bahtouee, et al.
World Journal of Nuclear Medicine|May 3, 2022
Comparison of <sup>18</sup> F-NaF Imaging, <sup>99m</sup> Tc-MDP Scintigraphy, and <sup>18</sup> F-FDG for Detecting Bone MetastasesHabibollah Dadgar, Nasim Norouzbeigi, Narges Jokar, et al.
Pageof 3